{"id":"topical-adapalene-gel-0-1","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Erythema"},{"rate":"10-25","effect":"Scaling"},{"rate":"10-20","effect":"Dryness"},{"rate":"5-15","effect":"Pruritus"},{"rate":"5-10","effect":"Photosensitivity"}]},"_chembl":{"chemblId":"CHEMBL1265","moleculeType":"Small molecule","molecularWeight":"412.53"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Adapalene selectively activates retinoic acid receptor gamma (RARγ) and other retinoid receptors, promoting keratinocyte differentiation and reducing comedone formation. It also exhibits anti-inflammatory properties by modulating cytokine production and reducing sebum production, making it effective for treating acne vulgaris.","oneSentence":"Adapalene is a third-generation retinoid that binds to retinoic acid receptors to normalize skin cell differentiation and reduce inflammation in acne.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:13:07.550Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris"}]},"trialDetails":[{"nctId":"NCT07473895","phase":"PHASE2","title":"Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT07348978","phase":"NA","title":"Auricular Acupressure Combined With Adapalene for the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2024-11-01","conditions":"Acne Vulgaris","enrollment":64},{"nctId":"NCT05582434","phase":"EARLY_PHASE1","title":"Experience With Topical Acne Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-02-15","conditions":"Acne","enrollment":72},{"nctId":"NCT07102186","phase":"PHASE4","title":"Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris","status":"RECRUITING","sponsor":"Badr University","startDate":"2025-07-21","conditions":"Acne Vulgaris","enrollment":120},{"nctId":"NCT07016360","phase":"PHASE4","title":"Comparison of Effectiveness of Topical Retinoids Versus Liquid Nitrogen in Treatment of Plantar Warts(Viral Infection)","status":"RECRUITING","sponsor":"Khyber Teaching Hospital","startDate":"2025-06-15","conditions":"Viral Warts","enrollment":98},{"nctId":"NCT00422240","phase":"PHASE3","title":"Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-06-27","conditions":"Acne Vulgaris","enrollment":1668},{"nctId":"NCT05536882","phase":"PHASE3","title":"MC RCT - BPO vs Adapalene","status":"WITHDRAWN","sponsor":"University of Oklahoma","startDate":"2022-05-18","conditions":"Molluscum Contagiosum","enrollment":""},{"nctId":"NCT00446043","phase":"PHASE3","title":"Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2004-02-17","conditions":"Acne Vulgaris","enrollment":452},{"nctId":"NCT04823845","phase":"EARLY_PHASE1","title":"Plantar Wart Treatment Using Adapalene Gel","status":"WITHDRAWN","sponsor":"University of Louisville","startDate":"2022-05-01","conditions":"Plantar Wart","enrollment":""},{"nctId":"NCT02249104","phase":"PHASE4","title":"A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2014-08","conditions":"Acne Vulgaris","enrollment":28},{"nctId":"NCT03573115","phase":"NA","title":"Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery","status":"COMPLETED","sponsor":"Merete Haedersdal","startDate":"2018-01-04","conditions":"Acne Vulgaris, Microparticles","enrollment":16},{"nctId":"NCT03832647","phase":"PHASE4","title":"Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne","status":"COMPLETED","sponsor":"Vichy Laboratoires","startDate":"2019-02-18","conditions":"Acne","enrollment":200},{"nctId":"NCT03563365","phase":"PHASE4","title":"The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol","status":"TERMINATED","sponsor":"Yardley Dermatology Associates","startDate":"2018-06-04","conditions":"Acne Vulgaris","enrollment":43},{"nctId":"NCT00421993","phase":"PHASE3","title":"A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-10","conditions":"Acne Vulgaris","enrollment":1670},{"nctId":"NCT00687908","phase":"PHASE3","title":"Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-11","conditions":"Acne","enrollment":243},{"nctId":"NCT01138735","phase":"PHASE4","title":"Epiduo Pediatric Acne Study","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-06","conditions":"Acne","enrollment":285},{"nctId":"NCT00688064","phase":"PHASE3","title":"Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-08","conditions":"Severe Acne Vulgaris","enrollment":459},{"nctId":"NCT01014689","phase":"PHASE3","title":"Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-08","conditions":"Acne Vulgaris","enrollment":378},{"nctId":"NCT01474590","phase":"PHASE3","title":"Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-11","conditions":"Acne","enrollment":266},{"nctId":"NCT00971282","phase":"PHASE4","title":"Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-12","conditions":"Healthy Skin","enrollment":30},{"nctId":"NCT04329403","phase":"PHASE3","title":"Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%","status":"WITHDRAWN","sponsor":"Aurobindo Pharma Ltd","startDate":"2020-07","conditions":"Acne Vulgaris","enrollment":""},{"nctId":"NCT03650881","phase":"NA","title":"The Comparative Efficacy of an Over the Counter Light Therapy Mask vs Over the Counter Topical Benzoyl Peroxide 2.5% and Used in Combination With Over the Counter Adapalene Gel 0.1% for Mild to Moderate Acne","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2018-08-07","conditions":"Acne","enrollment":""},{"nctId":"NCT01504204","phase":"PHASE4","title":"Effect of Samples on Acne Treatment With Epiduo® Gel","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2011-12","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT00757523","phase":"PHASE4","title":"Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-09-10","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT00926367","phase":"PHASE4","title":"Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-05","conditions":"Acne Vulgaris","enrollment":52},{"nctId":"NCT01387048","phase":"PHASE4","title":"Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin","status":"COMPLETED","sponsor":"University of Magdeburg","startDate":"2011-08","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT01501799","phase":"NA","title":"A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Actavis Mid-Atlantic LLC","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":885},{"nctId":"NCT00719121","phase":"PHASE1","title":"Study on Anti-inflammatory Effects of Topical R115866 Gel","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2006-11","conditions":"Cutaneous Inflammation","enrollment":12},{"nctId":"NCT01245946","phase":"PHASE2","title":"Photodynamic Therapy Compared to Adapalene 0.1% Gel Plus Doxycycline in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2010-10","conditions":"Acne","enrollment":46},{"nctId":"NCT00151541","phase":"PHASE3","title":"A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%","status":"COMPLETED","sponsor":"Allergan","startDate":"2005-02","conditions":"Acne Vulgaris","enrollment":301},{"nctId":"NCT01182636","phase":"PHASE1","title":"Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2007-07","conditions":"Acne Vulgaris","enrollment":601}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Topical Adapalene Gel 0.1%","genericName":"Topical Adapalene Gel 0.1%","companyName":"University of Louisville","companyId":"university-of-louisville","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Adapalene is a third-generation retinoid that binds to retinoic acid receptors to normalize skin cell differentiation and reduce inflammation in acne. Used for Acne vulgaris.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}